Inactive Instrument

Other languages Mirati Therapeutics

Equities

MRTX

US60468T1051

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

British billionaire Joe Lewis intends to plead guilty to US charges, lawyer says	Jan. 24
Bristol-Myers Squibb Closes Mirati Therapeutics Acquisition	Jan. 23
Bristol Myers : acquisition de Mirati Therapeutics finalisée	Jan. 23
Mirati Therapeutics, Inc. Announces Management Changes	Jan. 23
Bristol-Myers Squibb Company completed the acquisition of Mirati Therapeutics, Inc. from a group of shareholders.	Jan. 22
Mirati Therapeutics' Krazati Lung Cancer Treatment Gets EU Conditional Marketing Authorization	Jan. 10
Bristol Myers expects to launch 16 new products through 2030 - CEO	Jan. 08
Immunome Appoints Phil Roberts as Chief Technical Officer	Jan. 04
Bristol-Myers Squibb koopt RayzeBio	Dec. 26
US FDA turns down Amgen lung cancer drug Lumakras for full approval	Dec. 26
Bristol-Myers Agrees Deal to Buy RayzeBio for About $4.1 Billion	Dec. 26
Bristol Myers comprará a Karuna Therapeutics por 14.000 millones de dólares	Dec. 22
Bristol Myers rachète pour $14 mds Karuna Therapeutics et son traitement contre la schizophrénie	Dec. 22
Bristol-Myers Squibb Strikes $14 Billion Deal to Acquire Karuna Therapeutics	Dec. 22
Pharma und Gesundheit: weitere Konsolidierung	Dec. 13
Farma en gezondheid: consolidatie gaat door	Dec. 12
Farmaceutica e salute: continua il consolidamento	Dec. 11
Farmacia y salud: La consolidación continúa	Dec. 11
Pharma & santé : poursuite de la consolidation	Dec. 11
Mirati Therapeutics, Inc. Receives Positive Opinion from CHMP for KRAZATI as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer with a KRASG12C Mutation Following a Re-Examination Procedure	Nov. 10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Mirati Therapeutics

Equities

MRTX

US60468T1051

Other languages

Filters